C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI. | MicrobiomeTrials← Back to trialsNCT07250724
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-03-01Est. Completion: 2026-10-15
Enrollment target: 60 participants Locations- Emory University Hospital, Atlanta, Georgia, United States
- Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States
- Mayo Clinic, Minnesota, Rochester, Minnesota, United States
- University of Wisconsin-Madison, Madison, Wisconsin, United States
Other microbiome trials you might be interested in
Clostridium Difficile Infection
This is a Phase 1, first-in-human, double-blind, placebo-controlled, adaptive-design, single-site study, involving dose …
Knoxville, United StatesEst. completion Aug 22, 2028
Enterobacteriaceae InfectionsCarbapenem-Resistant Enterobacteriaceae InfectionImmunocompromised HostDrug Resistance, Multiple, Bacterial
The goal of this observational study is to learn about the effectiveness and safety of aztreonam-avibactam, an antibioti…
Buenos Aires, ArgentinaEst. completion Nov 1, 2028
Acute Respiratory Infection
This study will evaluate whether an expanded diagnostic strategy can reduce antibiotic use in patients aged 65 years or …
Elche, SpainEst. completion May 2027